pannus

(redirected from Corneal neovascularization)
Also found in: Medical, Encyclopedia, Wikipedia.
Related to Corneal neovascularization: corneal vascularization

pannus

(ˈpænəs)
n
(Veterinary Science) an inflammatory fleshy lesion on the surface of the eye
[C15: from Latin, literally cloth]
Translations

pan·nus

n. L. pannus, paño, membrana de tejido granulado que cubre una superficie normal.
References in periodicals archive ?
Limbal stem cell deficiency and corneal neovascularization.
Leucoma and corneal neovascularization on the left eye corneal surface were observed (Figure 2).
Global Markets Direct's, 'Corneal Neovascularization - Pipeline Review, H1 2016', provides an overview of the Corneal Neovascularization pipeline landscape.
Han and Zhang [sup][18] showed that Robo1 mediate inhibitory effect on corneal neovascularization.
The immediate start of topical treatment of the alkali-injured eye with antioxidant H2-enriched irrigation solution and N-acetyl-L-cysteine [1] or with bone marrow mesenchymal stem cells (BM-MSCs) revealing antioxidant properties significantly suppressed intracorneal inflammation and corneal neovascularization [2].
At 1 year after symptom onset, corneal limbal stem cell deficiency with deep corneal neovascularization was evident.
Limbal stem deficiency was made on presence of peripheral corneal neovascularization along with conjunctivalization.
USPRwire, Fri Sep 25 2015] GlobalData's clinical trial report, "Corneal Neovascularization Global Clinical Trials Review, H2, 2015" provides an overview of Corneal Neovascularization clinical trials scenario.
It also reviews key players involved in the therapeutic development for Corneal Neovascularization and special features on late-stage and discontinued projects.
Loss of corneal transparency with corneal opacification and infiltration by inflammatory cells in response to IL-1 are then a consequence of the above-mentioned factors with the occurrence of simultaneous stimulation of corneal neovascularization [1, 4].
Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
Eyes with high risk corneal transplantation with corneal neovascularization were included in this interventional study/randomized clinical trial.